Deoxypodophyllotoxin b

CAS No. 69222-20-4

Deoxypodophyllotoxin b( ——— )

Catalog No. M39805 CAS No. 69222-20-4

Isoanthricin ((Rac)-Deoxypodophyllotoxin) is the racemate of Deoxypodophyllotoxin. Deoxypodophyllotoxin is a potent antitumor and anti-inflammatory agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1444 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Deoxypodophyllotoxin b
  • Note
    Research use only, not for human use.
  • Brief Description
    Isoanthricin ((Rac)-Deoxypodophyllotoxin) is the racemate of Deoxypodophyllotoxin. Deoxypodophyllotoxin is a potent antitumor and anti-inflammatory agent.
  • Description
    Isoanthricin ((Rac)-Deoxypodophyllotoxin) is the racemate of Deoxypodophyllotoxin. Deoxypodophyllotoxin is a potent antitumor and anti-inflammatory agent.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    69222-20-4
  • Formula Weight
    398.41
  • Molecular Formula
    C22H22O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Khaled M, et, al. Deoxypodophyllotoxin: a promising therapeutic agent from herbal medicine. J Ethnopharmacol. 2013 Aug 26;149(1):24-34.?
molnova catalog
related products
  • ATMP

    ATMP is a phosphonic acid with chelating properties. It is an antiscalant.

  • [Tyr0] Gastric Inhib...

    [Tyr0] Gastric Inhibitory Peptide (23-42), human; [Tyr22] Gastric Inhibitory Peptide (22-42), human

  • SRI-011381 hydrochlo...

    SRI-011381 a new-type agonist of the TGF-beta signaling pathway is utilized in the treatment of Alzheimer's disease.